Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gamida Cell Ltd
(NQ:
GMDA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gamida Cell Ltd
< Previous
1
2
3
4
5
6
7
Next >
Why Is Gamida Cell (GMDA) Stock Up 48% Today?
April 18, 2023
Gamida Cell (GMDA) stock is taking off on Tuesday after getting an update from the FDA concerning cell therapy Omisirge.
Via
InvestorPlace
Why Digital Brands Group Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket
April 18, 2023
Gainers Super League Gaming, Inc. (NASDAQ: SLGG) jumped 119.8% to $0.9408 in pre-market trading. LandVault and Super League disclosed a strategic partnership to provide brands with scalable solutions...
Via
Benzinga
Promising Upsides on these Biotech Penny Stocks
April 18, 2023
These three biotech stocks each have a consensus Buy rating. While they are down from historic highs, impressive upsides make them worth consideration.
Via
MarketBeat
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 18, 2023
We're starting off the day with a look at the biggest pre-market stock movers traders will want to keep an eye on Tuesday!
Via
InvestorPlace
Gamida Cell Scores FDA Nod For Cord Blood-Based Cancer Therapy
April 18, 2023
Via
Benzinga
Earnings Outlook For Gamida Cell
March 24, 2023
Via
Benzinga
Earnings Preview: Gamida Cell
March 24, 2023
Via
Benzinga
Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval
April 17, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
March 28, 2023
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday!
Via
InvestorPlace
Earnings Scheduled For March 27, 2023
March 27, 2023
Companies Reporting Before The Bell • Viomi Technology Co (NASDAQ:VIOT) is likely to report earnings for its fourth quarter. • Vislink Technologies (NASDAQ:VISL) is projected to report earnings for its...
Via
Benzinga
Gamida Cell Reports Full Year 2022 Financial Results and Provides Company Update
March 27, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces Changes to Board of Directors
March 20, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces the Date of Its Fourth Quarter and Full Year 2022 Financial Results and Webcast
March 20, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell to Present Corporate Highlights at the Oppenheimer 33rd Annual Healthcare Conference
March 07, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Why Adial Pharmaceuticals Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
March 07, 2023
Gainers
Via
Benzinga
Data Presented on Gamida Cell’s Omidubicel, GDA-201 at the 2023 Tandem Meetings of ASTCT and CIBMTR
February 18, 2023
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces Closing of $25 Million Financing With Highbridge
December 12, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences
November 23, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 22, 2022
It's time to start the day with an overview of the biggest pre-market stock movers traders need to know about for Tuesday morning!
Via
InvestorPlace
Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday
November 23, 2022
Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on...
Via
Benzinga
Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
November 22, 2022
Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel...
Via
Benzinga
Why ObsEva Shares Are Trading Higher By Over 70%; Here Are 21 Stocks Moving Premarket
November 22, 2022
Gainers ObsEva SA (NASDAQ: OBSV) shares rose 71.9% to $0.2848 in pre-market trading after the company reported the sale of Ebopiprant license agreement to XOMA for up to $113 million.
Via
Benzinga
Gamida Cell Provides Regulatory Update on Omidubicel
November 21, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Pinterest To $23? Plus This Analyst Slashes PT On Neoleukin Therapeutics By More Than 90%
November 15, 2022
Rosenblatt raised the price target on Pinterest, Inc. (NYSE: PINS) from $21 to $23. Rosenblatt analyst Barton Crockett maintained a Neutral rating on the stock. Pinterest shares rose 2% to $24.91 in...
Via
Benzinga
Intellia Therapeutics To Rally Around 143%? Plus Stifel Cuts PT On This Stock By 94%
November 15, 2022
Chardan Capital boosted the price target on Intellia Therapeutics, Inc. (NASDAQ: NTLA) from $121 to $129. Intellia Therapeutics shares fell 3% to close at $53.30 on Monday.
Via
Benzinga
Gamida Cell Reports Third Quarter 2022 Financial Results and Provides Company Update
November 14, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell to Present Corporate Highlights at the Jefferies London Healthcare Conference
November 10, 2022
From
Gamida Cell Ltd.
Via
Business Wire
GDA-501, NAM enabled NK Cell Therapy, Demonstrates Promising Antitumor Activity Against HER2+ Cancers
November 07, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces the Date of Its Third Quarter 2022 Financial Results and Webcast
November 07, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces Omidubicel Data To Be Presented as an Oral Presentation at 64th ASH Annual Meeting
November 03, 2022
From
Gamida Cell Ltd.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.